“ 一典二目 ” 中少数民族药成方制剂的统计与分析  

Statistics and Analysis on the Ethnic Patent Medicine in the Chinese Pharmacopeia,National Essential Medicine List,and National Basic Medical Insurance,Employment Injury Insurance and Maternity Insurance Medicine List of China

作　　者：王玉艳 李晴晴 王志昊 明文华 李鹰飞[2] 李彦文[4] 李志勇[2] WANG Yuyan;LI Qingqing;WANG Zhihao;MING Wenhua;LI Yingfei;LI Yanwen;LI Zhiyong(School of Traditional Chinese Medicine,Shandong University of Traditional Chinese Medicine,Jinan 250355,China;Institute of Chinese Materia Medica,China Academy of Chinese Medical Sciences,Beijing 100700,China;Basic Medical College,Shanxi University of Traditional Chinese Medicine,Jinzhong 030619,China;Institute of Information on Traditional Chinese Medicine of China Academy of Chinese Medical Sciences,Beijing 100700,China)

机构地区：[1]山东中医药大学中医学院,济南250355 [2]中国中医科学院中药研究所,北京100700 [3]山西中医药大学基础医学院,晋中030619 [4]中国中医科学院中医药信息研究所,北京100700

出　　处：《医药导报》2025年第5期743-752,共10页Herald of Medicine

基　　金：常用少数民族医饮片名称梳理和中药名称对照研究(ZXYJHMZYYS2024-016)。

摘　　要：目的对《中华人民共和国药典》《国家基本医疗保险工伤保险和生育保险药品目录》和《国家基本药物目录》(简称“一典二目”)中的少数民族药成方制剂进行统计与分析。方法整理“一典二目”中收录的少数民族药成方制剂及其生产厂家、使用药材及现行质量标准;分析其功能主治、不良反应、禁忌及注意事项;通过中国国家知识基础设施(CNKI)和PubMed查询相关文献,分析上述成方制剂的现代研究水平。结果“一典二目”收录的142个民族药成方制剂,有独家品种68个,98.75%的药材有省级及以上质量标准;存在说明书中主治功能的表达医学术语混用,91.55%的说明书中不良反应、禁忌、注意事项信息不完善和现代基础研究薄弱等问题。结论民族药成方制剂在发展中需要重视说明书中不良反应、禁忌、注意事项信息的完善,在主治功能的表达上需避免医学术语混用,更有利于民族药成方制剂的临床推广。Objective In this paper,the ethnic patent medicines(EPMs)in the Chinese Pharmacopeia,National Basic Medical Insurance,Employment Injury Insurance and Maternity Insurance Medicine List,and National Essential Medicine List(referred to as“one pharmacopeia and two lists”)were counted and analyzed.Methods The EPMs in“one pharmacopeia and two lists”were summarized,and the information of manufacturers,medicinal materials used in EPMs,and their current quality standards were collated,and their indicative function,adverse reactions,contraindications,and precautions were analyzed.The modern research level of the above EPMs was analyzed by searching relevant literature on CNKI and PubMed.Results A total of 142 EPMs in“one pharmacopeia and two lists”were included,and 68 of the EPMs had exclusive manufacturers and 98.75%of the medicinal materials had provincial-level or higher quality standards.There were issues such as the expression of indicative function in the instruction being mixed between medical terms,91.55%of the EPMs lacking sufficient information on adverse reactions,contraindications,and precautions,and modern basic research was weak.Conclusions In the development of EPMs,it is important to improve information on adverse reactions,contraindications,and precautions in the instructions.In expressing indicative function,it is necessary to avoid mixing medical terms,which is more conducive to the clinical promotion of EPMs.

关 键 词：中华人民共和国药典 国家基本医疗保险工伤保险和生育保险药品目录 国家基本药物目录 民族药成方制剂 

分 类 号：R286[医药卫生—中药学] R926[医药卫生—中医学]